Paul Hudson

Chief Executive Officer at Sanofi

Paul Hudson

Paul Hudson

Chief Executive Officer at Sanofi

Overview
Career Highlights

AstraZeneca KK
AstraZéneca Farmacéutica Spain SA
Sanofi

RelSci Relationships

1959

Number of Boards

5

Birthday

10/1967

Age

53

Contact Data
Trying to get in touch with Paul Hudson? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
RelSci Relationships are individuals Paul Hudson likely has professional access to. A relationship does not necessarily indicate a personal connection.

Chief Corporate Affairs Officer at Cerevel Therapeutics LLC

Relationship likelihood: Strong

Executive Vice President & Chief Financial Officer at Sanofi

Relationship likelihood: Strong

Executive Vice President, Legal Affairs & General Counsel at Sanofi

Relationship likelihood: Strong

Executive Vice President, Chief People Officer at Sanofi

Relationship likelihood: Strong

Chief Digital Officer & Executive Vice President at Sanofi

Relationship likelihood: Strong

Executive Vice President, Global Head of Research & Development at Sanofi

Relationship likelihood: Strong

Founder at Biotechnology Innovation Organization

Relationship likelihood: Strong

President at International Council of Ophthalmology Foundation

Relationship likelihood: Strong

Former Executive Chairman at Envisia Therapeutics, Inc.

Relationship likelihood: Strong

Secretary, Executive Vice President & General Counsel at Regeneron Pharmaceuticals, Inc.

Relationship likelihood: Strong

Paths to Paul Hudson
Potential Connections via
Relationship Science
You
Paul Hudson
Chief Executive Officer at Sanofi
Education
Economics
Class of 1990

Manchester Metropolitan University is one of the most popular universities in the UK, in the UK’s most popular student city.

Career History
President-Astrazeneca US & Executive Vice President-North America
2006 - 2016

AstraZeneca Plc is a holding company, which engages in the research, development, and manufacture of pharmaceutical products. Its pipeline are used for the following therapy areas: oncology, cardiovascular, renal, metabolism, and respiratory. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.

Head of Biologics Global Marketing
Prior

Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ.

Chief Executive Officer
2016 - 2019

Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ.

Boards & Committees
Member, Board of Directors
2019 - Current

Sanofi, a diversified global healthcare leader, discovers, develops, and distributes therapeutic solutions to improve the lives of everyone. We work to prevent and treat the diseases that we know of today, as well as those we may face tomorrow. With nearly 100,000 dedicated professionals in more than 100 countries, Sanofi is devoted to advancing healthcare around the world. Sanofi US, with headquarters in Bridgewater, New Jersey, along with our vaccines division, Sanofi Pasteur, employs more than 11,400 professionals throughout the country. At Sanofi, we work for what really matters: health

Chairman
Current

Novartis Pharma KK develops, imports, produces and sells pharmaceutical products. The company was founded on April 1, 1997 and is headquartered in Tokyo, Japan.

Member, Executive Committee
2016 - 2019

Novartis AG is a holding company, which engages in the development, manufacture, and marketing of healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. The Innovative Medicines segment researches, develops, manufactures, distributes and sells patented pharmaceuticals, and is composed of two business units: Novartis Oncology and Novartis Pharmaceuticals. The Sandoz segment develops, manufactures and markets finished dosage form medicines as well as intermediary products including active pharmaceutical ingredients. The Corporate segment refers to group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.

Member, Health Section Governing Board
Current

Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Paul Hudson. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Paul Hudson's profile does not indicate a business or promotional relationship of any kind between RelSci and Paul Hudson.